- Associated Press - Friday, August 14, 2015

ZEBULON, N.C. (AP) - Drugmaker GlaxoSmithKline plans to resume operations at a North Carolina plant that closed after discovery of bacteria that cause Legionnaires’ disease, a potentially fatal form of pneumonia.

GSK said in a statement Friday the plant in Zebulon that produces inhaled medications will reopen Monday. It had closed Aug. 11 after testing found the bacteria in cooling towers.

The London-based company said the towers have been cleaned and disinfected. About 400 employees were told to stay away until the towers were cleaned.

The same bacteria found in water tanks in the Bronx section of New York City caused 12 Legionnaires’ disease deaths this summer. The Centers for Disease Control and Prevention says about 8,000 to 18,000 Americans are hospitalized with the illness annually.

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.

 

Click to Read More

Click to Hide